These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 1732665)

  • 21. Dysmegakaryopoiesis in myelodysplastic syndromes (MDS): an immunomorphometric study of bone marrow trephine biopsy specimens.
    Thiele J; Quitmann H; Wagner S; Fischer R
    J Clin Pathol; 1991 Apr; 44(4):300-5. PubMed ID: 2030148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survivin expression in "low-risk" and "high-risk" myelodysplastic syndromes.
    Gianelli U; Fracchiolla NS; Cortelezzi A; Pellegrini C; Savi F; Moro A; Grimoldi MG; Deliliers GL; Coggi G; Bosari S
    Ann Hematol; 2007 Mar; 86(3):185-9. PubMed ID: 17124585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flow cytometry in myelodysplastic syndrome: analysis of diagnostic utility using maturation pattern-based and quantitative approaches.
    Chopra A; Pati H; Mahapatra M; Mishra P; Seth T; Kumar S; Singh S; Pandey S; Kumar R
    Ann Hematol; 2012 Sep; 91(9):1351-62. PubMed ID: 22526362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic relevance of histological findings on bone marrow biopsy in myelodysplastic syndromes.
    Lambertenghi-Deliliers G; Annaloro C; Oriani A; Soligo D; Pozzoli E; Polli EE
    Ann Hematol; 1993 Feb; 66(2):85-91. PubMed ID: 8448244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myelofibrosis in primary myelodysplastic syndromes: clinical and biological significance.
    Marisavljević D; Rolović Z; Cemerikić V; Bosković D; Colović M
    Med Oncol; 2004; 21(4):325-31. PubMed ID: 15579916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes.
    Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
    Int J Hematol; 1993 Aug; 58(1-2):53-61. PubMed ID: 8219112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Revisiting the most often used item in the haematological tool box-The extent of haemodilution in bone marrow aspirates.
    Hokland P
    Br J Haematol; 2024 May; 204(5):1593-1594. PubMed ID: 38602310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histological and cytogenetic characterization of bone marrow in relation to prognosis and diagnosis of myelodysplastic syndromes.
    Sakuma T; Hayashi Y; Kanomata N; Murayama T; Matsui T; Kajimoto K; Hanioka K; Chihara K; Maeda S
    Pathol Int; 2006 Apr; 56(4):191-9. PubMed ID: 16634964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoplastic myelodysplastic syndrome.
    Nand S; Godwin JE
    Cancer; 1988 Sep; 62(5):958-64. PubMed ID: 3409176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of massively diluted bone marrow cell samples aspirated from patients with myelodysplastic syndromes (MDS) or suspected of MDS: A retrospective analysis of nationwide samples in Japan.
    Ogata K; Mochimaru Y; Kasai N; Sei K; Kawahara N; Ogata M; Yamamoto Y
    Br J Haematol; 2024 May; 204(5):1856-1861. PubMed ID: 38590011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Matrix metalloproteinase-9 in plasma of bone marrow aspirates of patients with acute myeloid leukemia and myelodysplastic syndrome].
    Lesnichenko IF; Kostroma II; Gritsaev SV; Chechetkin AV; Abdulkadyrov KM
    Vopr Onkol; 2016; 62(1):101-3. PubMed ID: 30444586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone marrow trephine biopsy involvement by lymphoma: review of histopathological features in 511 specimens and correlation with diagnostic biopsy, aspirate and peripheral blood findings.
    Sovani V; Harvey C; Haynes AP; McMillan AK; Clark DM; O'Connor SR
    J Clin Pathol; 2014 May; 67(5):389-95. PubMed ID: 24327662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis on laboratory and clinical characteristics in 65 cases of myelodysplastic syndrome].
    Chen BA; Gao C; Ding J; Ding JH; Sun YY; Zhao G; Cheng J; Wang J; Bao W; Song HH; Xia GH; Ma JL; Wu LL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1472-6. PubMed ID: 20030929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of risk groups in myelodysplastic syndromes. A multicenter study.
    Belli C; Acevedo S; Bengio R; Arrossagaray G; Watman N; Rossi N; García J; Flores G; Goldztein S; Larripa I
    Haematologica; 2002 Jan; 87(1):9-16. PubMed ID: 11801460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imbalance between apoptosis and telomerase activity in myelodysplastic syndromes: possible role in ineffective hemopoiesis.
    Ohshima K; Karube K; Shimazaki K; Kamma H; Suzumiya J; Hamasaki M; Kikuchi M
    Leuk Lymphoma; 2003 Aug; 44(8):1339-46. PubMed ID: 12952227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone marrow trephine interpretation: diagnostic utility and potential pitfalls.
    De Wolf-Peeters C
    Histopathology; 1991 Jun; 18(6):489-93. PubMed ID: 1879808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone marrow histology in myelodysplastic syndromes.
    Frisch B; Bartl R
    Scand J Haematol Suppl; 1986; 45():21-37. PubMed ID: 3457444
    [No Abstract]   [Full Text] [Related]  

  • 38. Additional prognostic impact of the percentage of erythroid cells in the bone marrow of patients with myelodysplastic syndromes.
    Neukirchen-Strapatsas J; Tuechler H; Porta MD; Fenaux P; Guerci A; Haas R; Rossi M; Sapena R; Sperr WR; Strupp C; Stamatoullas A; Valent P; Germing U; Bennett JM
    Leuk Res; 2019 Feb; 77():8-13. PubMed ID: 30605856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic implications of bone marrow culturing in myelodysplastic syndrome: a retrospective analysis.
    Raymakers R; Preijers F; Boezeman J; Rutten E; De Witte T
    Leuk Lymphoma; 1994 Jun; 14(1-2):111-20. PubMed ID: 7920217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased Multinucleated Megakaryocytes as an Isolated Finding in Bone Marrow:  A Rare Finding and Its Clinical Significance.
    Jawad MD; Go RS; Reichard KK; Shi M
    Am J Clin Pathol; 2016 Nov; 146(5):561-566. PubMed ID: 28430954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.